Novavax says its COVID-19 vaccine shows promising results in early study
August 04, 2020 at 17:44 PM EDT
Novavax Inc. said Tuesday its experimental coronavirus vaccine induced promising immune responses and was generally well-tolerated in healthy adults in the first human study of the shot.
